{
    "clinical_study": {
        "@rank": "63652", 
        "arm_group": {
            "arm_group_label": "Delivery volume", 
            "arm_group_type": "Experimental", 
            "description": "Deliver 0.1, 0.25 and 0.5 mL volumes of saline via FLUGEN 101.2 device to non-overlapping injection sites."
        }, 
        "brief_summary": {
            "textblock": "This study will evaluate intracutaneous delivery of 0.1, 0.25 and 0.5 milliliter volumes of\n      saline from the FLUGEN 101.2 investigational microneedle-based device."
        }, 
        "brief_title": "Intracutaneous Delivery of Varied Dose Volumes of Saline", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Intracutaneous Drug Delivery", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Able to read and/or understand and sign the Informed Consent form\n\n        Exclusion Criteria:\n\n          -  Medical history of acute or chronic skin disease\n\n          -  Active skin allergy or acute skin infection, presence of tattoo(s), scars, sunburn or\n             skin abnormalities at any prospective injection site\n\n          -  Hirsute at any prospective injection site\n\n          -  Diabetes\n\n          -  High levels of anxiety or depression or history of psychosis\n\n          -  Abuse of alcohol or use of other drugs of abuse including tobacco\n\n          -  Pregnant or breastfeeding women\n\n          -  Any medical condition that may interfere with study protocol adherence including\n             completion of study activities\n\n          -  Foreseeable inability to complete the study as scheduled."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "49 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01767337", 
            "org_study_id": "FGN-NSR-2012-002"
        }, 
        "intervention": {
            "arm_group_label": "Delivery volume", 
            "intervention_name": "FLUGEN 101.2 microneedle-based delivery device", 
            "intervention_type": "Device", 
            "other_name": "FLUGEN 101.2"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "microneedle-based delivery", 
            "hollow microneedle", 
            "intracutaneous", 
            "drug delivery"
        ], 
        "lastchanged_date": "January 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Melbourne", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32935"
                }, 
                "name": "Accelovance Inc"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Exploratory Evaluation of Healthy Subjects Receiving Varied Dose Volumes of Saline Delivered by a Non-Significant Risk Investigational Device Utilizing a Micro-Needle Array", 
        "overall_official": [
            {
                "affiliation": "FluGen Inc", 
                "last_name": "Renee Herber", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Accelovance Inc.", 
                "last_name": "Murray A Kimmel, DO", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Observe injection sites for change of appearance post-dose including initial wheal formation and subsequent resolution.", 
            "measure": "The primary objective is to evaluate the safety and tolerability/reactogenicity of various saline volumes delivered from the FLUGEN 101.2 microneedle-based device as evidenced by change of dose site appearance over time.", 
            "safety_issue": "Yes", 
            "time_frame": "30 minutes, 24 hours, ~ 1 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01767337"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Evaluate ability of device to dispense targeted dose volume.", 
            "measure": "A secondary objective of this study is to evaluate the mechanical elimination of fluid from the device.", 
            "safety_issue": "No", 
            "time_frame": "3 minutes"
        }, 
        "source": "FluGen Inc", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Pearl Pathways, LLC", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Accelovance Inc.", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "FluGen Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}